Transaction DateRecipientSharesTypePriceValue
15th December 2020Mark A Sirgo230,769Open or private purchase$0.65$149,999.85
15th December 2020John Temperato153,846Open or private purchase$0.65$99,999.90
15th December 2020Edward J Sitar61,538Open or private purchase$0.65$39,999.70
2nd December 2020Israel Gp Ltd. Orbi Med103,200Open or private sale$21.60$2,229,120.00
27th November 2020John Temperato203,667Grant/award etc.$0.00
9th November 2020Lorin K Johnson4,262Exercise of in-the-money or at-the-money derivatives securities (usually options)$4.00$17,048.00
30th October 2020Israel Gp Ltd. Orbi Med1,943,734Other acquisition or disposition$0.00
30th October 2020Nissim Darvish1,943,734Other acquisition or disposition$0.00
30th October 2020Mark A Sirgo4,513Other acquisition or disposition$0.00
30th October 2020John Temperato4,513Other acquisition or disposition$0.00
9 Meters Biopharma
9 Meters Biopharma logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

Innovate Biopharmaceuticals, Inc. is a clinical-stage biopharm Pharmaceutical company. The company is founded by Jay P. Madan and Kendyle Woodard in 2012.

Ticker: INNT
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1551986
Employees: 8
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags